Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, IONS, NBIX, ISRG, ITCI, and represent 25.69% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: MRK (+$22M), BRKR (+$21M), AMGN (+$17M), EHC (+$16M), SRRK (+$15M), THC (+$13M), MOH, MASI, STE, TMO.
- Started 13 new stock positions in Moderna Inc call, PTCT, OCS, QURE, SPY, MASI, ASND, BTSG, KNSA, BRKR. ZLAB, ROIV, GDX.
- Reduced shares in these 10 stocks: OPCH (-$52M), EPIX (-$48M), EXAS (-$42M), , TNDM (-$39M), CDNA (-$38M), VRTX (-$34M), UNH (-$33M), VRNA (-$30M), CRSP (-$29M).
- Sold out of its positions in APLS, EPIX, EXEL, GBIO, HCM, IDYA, MTEM, NKE, OABI, OPCH. RCKT, SNY, Summit Therapeutics, VTRS, CRSP.
- Bellevue Group was a net seller of stock by $-665M.
- Bellevue Group has $5.2B in assets under management (AUM), dropping by -15.84%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bellevue Group
Bellevue Group holds 161 positions in its portfolio as reported in the December 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 7.0 | $365M | -6% | 593k | 615.00 |
|
| Ionis Pharmaceuticals (IONS) | 5.3 | $275M | 7.9M | 34.96 |
|
|
| Neurocrine Biosciences (NBIX) | 4.8 | $248M | -2% | 1.8M | 136.50 |
|
| Intuitive Surgical Com New (ISRG) | 4.7 | $242M | -6% | 464k | 521.96 |
|
| Intra Cellular Therapies (ITCI) | 3.9 | $204M | 2.4M | 83.52 |
|
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $196M | -14% | 487k | 402.70 |
|
| Revolution Medicines (RVMD) | 3.7 | $192M | -9% | 4.4M | 43.74 |
|
| Abbott Laboratories (ABT) | 3.7 | $191M | -3% | 1.7M | 113.11 |
|
| Boston Scientific Corporation (BSX) | 3.7 | $191M | -12% | 2.1M | 89.32 |
|
| Stryker Corporation (SYK) | 3.6 | $187M | 520k | 360.05 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 3.5 | $181M | -4% | 770k | 235.31 |
|
| Incyte Corporation (INCY) | 2.9 | $149M | 2.2M | 69.07 |
|
|
| Agios Pharmaceuticals (AGIO) | 2.2 | $116M | -5% | 3.5M | 32.86 |
|
| Scholar Rock Hldg Corp (SRRK) | 2.1 | $109M | +16% | 2.5M | 43.22 |
|
| Insulet Corporation (PODD) | 1.6 | $84M | -23% | 322k | 261.07 |
|
| Medtronic SHS (MDT) | 1.6 | $83M | +3% | 1.0M | 79.88 |
|
| Edwards Lifesciences (EW) | 1.6 | $81M | -3% | 1.1M | 74.03 |
|
| Dex (DXCM) | 1.6 | $81M | +2% | 1.0M | 77.77 |
|
| UnitedHealth (UNH) | 1.6 | $81M | -29% | 160k | 505.86 |
|
| Celldex Therapeutics Com New (CLDX) | 1.5 | $78M | 3.1M | 25.27 |
|
|
| Becton, Dickinson and (BDX) | 1.5 | $77M | 338k | 226.87 |
|
|
| Biohaven (BHVN) | 1.5 | $76M | 2.0M | 37.35 |
|
|
| Moderna (MRNA) | 1.3 | $67M | 1.6M | 41.58 |
|
|
| Penumbra (PEN) | 1.1 | $57M | -12% | 238k | 237.48 |
|
| Wave Life Sciences SHS (WVE) | 1.0 | $51M | 4.1M | 12.37 |
|
|
| Arvinas Ord (ARVN) | 0.9 | $46M | 2.4M | 19.17 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.8 | $41M | 524k | 78.18 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.8 | $39M | -52% | 694k | 56.19 |
|
| Edgewise Therapeutics (EWTX) | 0.7 | $38M | 1.4M | 26.70 |
|
|
| Beam Therapeutics (BEAM) | 0.7 | $38M | 1.5M | 24.80 |
|
|
| Procept Biorobotics Corp (PRCT) | 0.7 | $37M | -24% | 463k | 80.52 |
|
| ResMed (RMD) | 0.7 | $37M | 161k | 228.69 |
|
|
| Immunocore Hldgs Ads (IMCR) | 0.7 | $36M | 1.2M | 29.50 |
|
|
| Eli Lilly & Co. (LLY) | 0.7 | $35M | +2% | 46k | 772.00 |
|
| Cigna Corp (CI) | 0.7 | $35M | +5% | 125k | 276.14 |
|
| Align Technology (ALGN) | 0.6 | $33M | +11% | 160k | 208.51 |
|
| Cooper Cos (COO) | 0.6 | $33M | -10% | 357k | 91.93 |
|
| Macrogenics (MGNX) | 0.6 | $32M | 9.9M | 3.25 |
|
|
| IDEXX Laboratories (IDXX) | 0.6 | $32M | -15% | 77k | 413.44 |
|
| Thermo Fisher Scientific (TMO) | 0.6 | $32M | +13% | 61k | 520.23 |
|
| Zimmer Holdings (ZBH) | 0.6 | $31M | -32% | 294k | 105.63 |
|
| Relay Therapeutics (RLAY) | 0.6 | $30M | 7.4M | 4.12 |
|
|
| Globus Med Cl A (GMED) | 0.6 | $30M | -22% | 363k | 82.71 |
|
| Caredx (CDNA) | 0.6 | $29M | -56% | 1.4M | 21.41 |
|
| Tandem Diabetes Care Com New (TNDM) | 0.5 | $28M | -57% | 783k | 36.02 |
|
| Danaher Corporation (DHR) | 0.5 | $28M | +13% | 120k | 229.55 |
|
| Inspire Med Sys (INSP) | 0.5 | $28M | -23% | 149k | 185.38 |
|
| Veeva Sys Cl A Com (VEEV) | 0.5 | $27M | -21% | 128k | 210.25 |
|
| Annexon (ANNX) | 0.5 | $27M | 5.2M | 5.13 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $26M | -53% | 569k | 46.44 |
|
| Merck & Co (MRK) | 0.5 | $26M | +525% | 264k | 99.48 |
|
| Sage Therapeutics (SAGE) | 0.5 | $24M | 4.5M | 5.43 |
|
|
| Molina Healthcare (MOH) | 0.5 | $24M | +21% | 82k | 291.05 |
|
| Amgen (AMGN) | 0.4 | $23M | +254% | 89k | 260.64 |
|
| Natera (NTRA) | 0.4 | $23M | +5% | 146k | 158.30 |
|
| Steris Shs Usd (STE) | 0.4 | $23M | +20% | 110k | 205.56 |
|
| Regeneron Pharmaceuticals (REGN) | 0.4 | $22M | +17% | 31k | 712.33 |
|
| Esperion Therapeutics (ESPR) | 0.4 | $22M | 9.9M | 2.20 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.4 | $22M | 329k | 65.73 |
|
|
| Bruker Corporation (BRKR) | 0.4 | $21M | NEW | 360k | 58.62 |
|
| Sarepta Therapeutics (SRPT) | 0.4 | $21M | -50% | 171k | 121.59 |
|
| Castle Biosciences (CSTL) | 0.4 | $20M | -40% | 746k | 26.65 |
|
| Privia Health Group (PRVA) | 0.4 | $19M | -10% | 953k | 19.55 |
|
| Hca Holdings (HCA) | 0.4 | $19M | -45% | 62k | 300.15 |
|
| Black Diamond Therapeutics (BDTX) | 0.4 | $18M | 8.5M | 2.14 |
|
|
| Hologic (HOLX) | 0.3 | $18M | 248k | 72.09 |
|
|
| Insmed Com Par $.01 (INSM) | 0.3 | $18M | -50% | 259k | 69.04 |
|
| AmerisourceBergen (COR) | 0.3 | $17M | +7% | 78k | 224.68 |
|
| Encompass Health Corp (EHC) | 0.3 | $17M | +880% | 189k | 92.35 |
|
| Neogenomics Com New (NEO) | 0.3 | $17M | -34% | 1.1M | 16.48 |
|
| Anthem (ELV) | 0.3 | $14M | -57% | 38k | 368.90 |
|
| Tenet Healthcare Corp Com New (THC) | 0.3 | $14M | +1859% | 110k | 126.23 |
|
| Structure Therapeutics Sponsord Ads (GPCR) | 0.3 | $13M | -22% | 485k | 27.12 |
|
| Evolent Health Cl A (EVH) | 0.2 | $13M | -58% | 1.1M | 11.25 |
|
| Si-bone (SIBN) | 0.2 | $12M | -38% | 881k | 14.02 |
|
| Transmedics Group (TMDX) | 0.2 | $12M | +13% | 193k | 62.35 |
|
| Bio Rad Labs Cl A (BIO) | 0.2 | $11M | -27% | 34k | 328.51 |
|
| McKesson Corporation (MCK) | 0.2 | $11M | -45% | 19k | 569.91 |
|
| Phreesia (PHR) | 0.2 | $10M | -3% | 406k | 25.16 |
|
| Axsome Therapeutics (AXSM) | 0.2 | $10M | -67% | 119k | 84.61 |
|
| Charles River Laboratories (CRL) | 0.2 | $9.3M | -31% | 50k | 184.60 |
|
| Glaukos (GKOS) | 0.2 | $9.1M | -3% | 61k | 149.94 |
|
| Iqvia Holdings (IQV) | 0.2 | $8.8M | -65% | 45k | 196.51 |
|
| Abbvie (ABBV) | 0.2 | $8.0M | +5% | 45k | 177.70 |
|
| Fate Therapeutics (FATE) | 0.2 | $8.0M | 4.8M | 1.65 |
|
|
| Johnson & Johnson (JNJ) | 0.2 | $7.9M | +6% | 55k | 144.62 |
|
| Humana (HUM) | 0.1 | $7.2M | 28k | 253.71 |
|
|
| Altimmune Com New (ALT) | 0.1 | $6.8M | +9% | 945k | 7.21 |
|
| Astrana Health Com New (ASTH) | 0.1 | $6.5M | -19% | 205k | 31.53 |
|
| Beigene Sponsored Adr (ONC) | 0.1 | $6.3M | -41% | 34k | 184.71 |
|
| Terns Pharmaceuticals (TERN) | 0.1 | $5.9M | 1.1M | 5.54 |
|
|
| Illumina (ILMN) | 0.1 | $5.8M | -3% | 44k | 133.63 |
|
| Waystar Holding Corp (WAY) | 0.1 | $5.8M | +5% | 158k | 36.70 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $5.4M | 167k | 32.54 |
|
|
| Centene Corporation (CNC) | 0.1 | $5.2M | 87k | 60.58 |
|
|
| Gilead Sciences (GILD) | 0.1 | $4.5M | +5% | 48k | 92.37 |
|
| Omnicell (OMCL) | 0.1 | $4.2M | -52% | 95k | 44.52 |
|
| Masimo Corporation (MASI) | 0.1 | $4.0M | NEW | 24k | 165.30 |
|
| 10x Genomics Cl A Com (TXG) | 0.1 | $3.9M | -3% | 271k | 14.36 |
|
| Pfizer (PFE) | 0.1 | $3.8M | 142k | 26.53 |
|
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.1 | $3.3M | NEW | 5.7k | 586.08 |
|
| Summit Therapeutics (SMMT) | 0.1 | $3.0M | +166% | 171k | 17.84 |
|
| Brightspring Health Svcs (BTSG) | 0.1 | $3.0M | NEW | 174k | 17.03 |
|
| Cardinal Health (CAH) | 0.1 | $2.6M | -26% | 22k | 118.27 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $2.6M | -3% | 378k | 6.76 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.0 | $2.3M | +6% | 36k | 65.52 |
|
| Bristol Myers Squibb (BMY) | 0.0 | $2.2M | +3% | 38k | 56.56 |
|
| Accolade (ACCD) | 0.0 | $2.1M | -3% | 616k | 3.42 |
|
| Zoetis Cl A (ZTS) | 0.0 | $1.6M | +85% | 9.8k | 162.93 |
|
| Dr Reddys Labs Adr (RDY) | 0.0 | $1.5M | +375% | 98k | 15.79 |
|
| Doximity Cl A (DOCS) | 0.0 | $1.5M | -3% | 28k | 53.39 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $1.3M | -14% | 61k | 22.04 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.0 | $1.3M | +50% | 24k | 55.98 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.0 | $1.1M | 6.0k | 190.44 |
|
|
| Vaxcyte (PCVX) | 0.0 | $985k | 12k | 81.86 |
|
|
| Certara Ord (CERT) | 0.0 | $981k | -3% | 92k | 10.65 |
|
| CVS Caremark Corporation (CVS) | 0.0 | $981k | 22k | 44.89 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 0.0 | $949k | -4% | 8.3k | 113.95 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $916k | +92% | 24k | 38.60 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $888k | NEW | 26k | 33.91 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $795k | +31% | 100k | 7.92 |
|
| Krystal Biotech (KRYS) | 0.0 | $791k | +5% | 5.0k | 156.66 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $643k | +224% | 25k | 25.70 |
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $550k | 40k | 13.93 |
|
|
| Viking Therapeutics (VKTX) | 0.0 | $521k | -20% | 13k | 40.24 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $515k | 11k | 47.04 |
|
|
| Biogen Idec (BIIB) | 0.0 | $406k | 2.7k | 152.92 |
|
|
| Travere Therapeutics (TVTX) | 0.0 | $402k | -25% | 23k | 17.42 |
|
| Uniqure Nv SHS (QURE) | 0.0 | $397k | NEW | 23k | 17.66 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.0 | $344k | NEW | 2.5k | 137.67 |
|
| Zai Lab Adr (ZLAB) | 0.0 | $341k | NEW | 13k | 26.19 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $339k | 1.1k | 308.57 |
|
|
| Merus N V (MRUS) | 0.0 | $336k | 8.0k | 42.05 |
|
|
| Xenon Pharmaceuticals (XENE) | 0.0 | $321k | 8.2k | 39.20 |
|
|
| Denali Therapeutics (DNLI) | 0.0 | $320k | 16k | 20.38 |
|
|
| Adma Biologics (ADMA) | 0.0 | $290k | -34% | 17k | 17.15 |
|
| Bridgebio Pharma (BBIO) | 0.0 | $285k | 10k | 27.44 |
|
|
| Roivant Sciences SHS (ROIV) | 0.0 | $284k | NEW | 24k | 11.83 |
|
| Blueprint Medicines (BPMC) | 0.0 | $279k | 3.2k | 87.22 |
|
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $238k | 4.4k | 54.15 |
|
|
| Arcellx Common Stock (ACLX) | 0.0 | $230k | -25% | 3.0k | 76.69 |
|
| Garmin SHS (GRMN) | 0.0 | $217k | 1.1k | 206.26 |
|
|
| Mineralys Therapeutics (MLYS) | 0.0 | $203k | 17k | 12.31 |
|
|
| Ptc Therapeutics I (PTCT) | 0.0 | $172k | NEW | 3.8k | 45.14 |
|
| Oculis Holding Ordinary Shares (OCS) | 0.0 | $170k | NEW | 10k | 17.00 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.0 | $169k | 2.0k | 84.31 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $168k | 4.0k | 42.07 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.0 | $160k | NEW | 8.1k | 19.78 |
|
| Nurix Therapeutics (NRIX) | 0.0 | $151k | 8.0k | 18.84 |
|
|
| Veracyte (VCYT) | 0.0 | $143k | 3.6k | 39.60 |
|
|
| Kura Oncology (KURA) | 0.0 | $119k | 14k | 8.71 |
|
|
| Moderna Call Call Option | 0.0 | $110k | NEW | 150.00 | 733.15 |
|
| Oracle Corporation (ORCL) | 0.0 | $109k | +4% | 654.00 | 166.64 |
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $108k | +4% | 806.00 | 134.34 |
|
| NVIDIA Corporation (NVDA) | 0.0 | $101k | +4% | 751.00 | 134.29 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $98k | 42k | 2.35 |
|
|
| Microsoft Corporation (MSFT) | 0.0 | $86k | +4% | 203.00 | 421.50 |
|
| Qualcomm (QCOM) | 0.0 | $69k | +4% | 447.00 | 153.62 |
|
| Mettler-Toledo International (MTD) | 0.0 | $51k | +2% | 42.00 | 1223.69 |
|
| Labcorp Holdings Com Shs (LH) | 0.0 | $50k | +4% | 216.00 | 229.32 |
|
| Tempus Ai Cl A (TEM) | 0.0 | $8.0k | -54% | 237.00 | 33.76 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q4 filed Feb. 14, 2025
- Bellevue Group 2024 Q3 filed Nov. 14, 2024
- Bellevue Group 2024 Q2 filed Aug. 14, 2024
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021